Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging
2021 · Alzheimer s & Dementia · 158 citations
https://doi.org/10.1002/alz.12369
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
164
Citations
3
h-index
1
i10-index
Philip Chan is an academic researcher from Hong Kong University of Science and Technology. The author has contributed to research in topics: Alzheimer's disease research and treatments & Metabolomics and Mass Spectrometry Studies & Dementia and Cognitive Impairment Research. The author has an h-index of 3, co-authored 3 publications.
https://doi.org/10.1002/alz.12369
https://doi.org/10.1002/alz.056099
Click to start Chat